Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 10671-10680 of 13618

Page
per page
  1. UCN-01
    C4783 UCN-01
    Summary: inhibitor of Akt, protein kinase C, PDK1 and cyclin-dependent kinases
      Soluble in DMSO
  2. 12(S)-hydroxy-16-Heptadecynoic Acid
    C5001 12(S)-hydroxy-16-Heptadecynoic Acid
    Summary: mechanism-based inhibitor of cytochrome P450 ω-hydroxylase
      ≤50 mg/mL
  3. BML-277
    B1236 BML-277
    Target: Chk
    Summary: Chk2 inhibitor,potent and highly selective
      insoluble in H2O; ≥18.2 mg/mL
  4. Haloperidol hydrochloride
    B1242 Haloperidol hydrochloride
    Summary: Antipsychotic drug
      insoluble in H2O; ≥10.31 mg/mL
  5. VU 0357121
    B1629 VU 0357121
    Summary: Novel positive allosteric modulator (PAM) of mGlu5
      Soluble in DMSO
  6. BAY 87-2243
    B1115 BAY 87-2243
    Target: Hypoxia Inducible Factors (HIFs)
    Summary: HIF-1 inhibitor,potent and selective
  7. Valsartan
    B2214 Valsartan
    Target: Angiotensin AT1 Receptors
    Summary: Angiotensin II AT1 receptor antagonist
  8. Tolterodine tartrate
    B1620 Tolterodine tartrate
    Target: AChR
    Summary: Competitive muscarinic receptor antagonist
      ≥23.78 mg/mL
  9. Pitavastatin
    B1124 Pitavastatin
     2 Citation
    Summary: HMG-CoA reductase inhibitor
      ≥10.56 mg/mL
  10. Cytidine
    B1923 Cytidine
    Summary: pyrimidine nucleoside
      insoluble in EtOH; ≥11.85 mg/mL

Items 10671-10680 of 13618

Page
per page